Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. W. Yancey"'
Autor:
B. Terrier, D. Jayne, B. Hellmich, J. H. Bentley, J. Steinfeld, S. W. Yancey, N. Kwon, P. Akuthota, P. Khoury, L. Baylis, M. Wechsler
Publikováno v:
Annals of the Rheumatic Diseases. 81:709-709
BackgroundPatients with eosinophilic granulomatosis with polyangiitis (EGPA) can present with vasculitic or eosinophilic phenotypes.1 The Phase III MIRRA study demonstrated that patients with EGPA spent more time in remission and had reduced oral cor
Publikováno v:
MedGenMed : Medscape general medicine. 3(4)
For asthmatic patients who remain symptomatic on inhaled corticosteroids, augmenting the therapy with additional long-term control medication is advocated. Long-acting beta2-adrenergic agonists and leukotriene modifiers are 2 therapeutic alternatives
Publikováno v:
Chest. 115(6)
To compare the efficacy, safety, and effects on sleep quality of salmeterol and extended-release theophylline in patients with nocturnal asthma.Randomized, double-blind, double-dummy, three-period crossover.Outpatients at a single center. Patients sp
Autor:
Art J. Heires, David M. Daughton, S. I. Rennard, T. L. Bohling, S. W. Yancey, Austin B. Thompson, M. B. Mueller, R. S. Sykes
Publikováno v:
Molecular Microbiology
Molecular Microbiology, 1992, 146 (2), pp.389-95. ⟨10.1046/j.1365-2958.2001.02530.x⟩
Molecular Microbiology, Wiley, 1992, 146 (2), pp.389-95. ⟨10.1046/j.1365-2958.2001.02530.x⟩
Molecular Microbiology, 1992, 146 (2), pp.389-95. ⟨10.1046/j.1365-2958.2001.02530.x⟩
Molecular Microbiology, Wiley, 1992, 146 (2), pp.389-95. ⟨10.1046/j.1365-2958.2001.02530.x⟩
International audience; Chronic bronchitis is associated with airways obstruction and inflammation. In order to determine whether aerosolized beclomethasone can modulate airway inflammation and diminish airway obstruction, subjects with chronic bronc
Autor:
Amy D. Klion, Florence Roufosse, Marc E. Rothenberg, Suyong Yun Kirby, Jane H Bentley, Jonathan Steinfeld, Martyn J. Gilson, Eric S. Bradford, Steven W. Yancey, Andrew J. Wardlaw, Jean-Emmanuel Kahn, Gerald J. Gleich
Publikováno v:
Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2020, 146 (6), pp.1397-1405. ⟨10.1016/j.jaci.2020.08.037⟩
Journal of allergy and clinical immunology
Journal of Allergy and Clinical Immunology, Elsevier, 2020, 146 (6), pp.1397-1405. ⟨10.1016/j.jaci.2020.08.037⟩
Journal of allergy and clinical immunology
Background: Anti–IL-5 therapy is a potential treatment for patients with hypereosinophilic syndrome (HES), although its clinical efficacy is unclear. Objective: We sought to investigate the clinical efficacy and safety of mepolizumab versus placebo